Volume 29, Number 6—June 2023
Research
SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022
Lauren E. Bloomfield, Sera Ngeh, Gemma Cadby, Kate Hutcheon, and Paul V. Effler
Table 2
ICD-10-AM hospital admission codes used to identify and categorize underlying conditions and construct a comorbidity score for each person included in a study of SARS-CoV-2 vaccine effectiveness, Western Australia, Australia, 2022*
| Underlying condition category | ICD-10-AM codes |
|---|---|
| Respiratory disease | J40–J47; J81; J84; E84 |
| Diabetes | E10–E14 |
| Anemia/splenic issues | D50–D59; D60–D63; D73 |
| Down syndrome | Q90 |
| Cancer | C00–C97 excl C44 |
| Kidney disease | N18–N19; N00–N16; N25–N29 |
| Immunocompromise | D80–D89; B24 |
| Dementia | F00–F03; G30 |
| Cardiac disease incl hypertension and arrhythmia | I20–I28; I05–I10; I47–I50 |
| Stroke/TIA | G45; H34; I60–I69 |
| Liver disease | K71–K77 |
| Obesity | E66 |
| Rheumatoid arthritis | M05–M06 |
| Ulcerative colitis/Crohn’s disease | K50–K51 |
*ICD-10-AM, International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification; TIA, transient ischemic attack.
Page created: April 19, 2023
Page updated: May 17, 2023
Page reviewed: May 17, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.